Accelovance: Bourne Partners Advises Accelovance on Sale to Linical
Accelovance Inc. Accelovance a global contract research organization CRO focused on oncology vaccines and general medicine has been acquired by Linical a leading Asiabased CRO providing services in the areas of oncology and central ...
Read full article »
Accelovance is a provider of digital contract research solutions for pharmaceutical, biotechnology and medical device companies.
Read more